Malignant germ cell tumor of the vagina

Malignant germ cell tumor of the vagina is an extremely rare neoplasm arising from germ cells that have aberrantly migrated to or persisted in the vaginal tissue. Germ cell tumors typically originate from primordial germ cells and can occur at gonadal or extragonadal sites; the vagina is a very uncommon extragonadal location. The most frequently reported histological subtype in this location is endodermal sinus tumor (yolk sac tumor), though other germ cell tumor types may also occur. This tumor predominantly affects infants and very young children, typically presenting before the age of 3 years. Key symptoms include vaginal bleeding or bloody vaginal discharge, a visible or palpable vaginal mass, and occasionally abdominal or pelvic discomfort. Serum alpha-fetoprotein (AFP) levels are often markedly elevated, serving as an important diagnostic and monitoring biomarker. The disease primarily affects the reproductive system, specifically the vaginal wall, but can invade locally into surrounding pelvic structures and may metastasize to regional lymph nodes, lungs, or other distant sites if not treated promptly. Diagnosis is established through biopsy and histopathological examination, supported by immunohistochemistry and elevated serum AFP levels. Imaging studies such as MRI and CT are used for staging. Treatment typically involves a combination of chemotherapy and surgery. Platinum-based chemotherapy regimens, particularly those including cisplatin (such as PEB: cisplatin, etoposide, and bleomycin), have significantly improved outcomes and often allow for more conservative surgical approaches, preserving vaginal anatomy and function. With modern multimodal treatment, survival rates have improved substantially compared to historical outcomes. Long-term follow-up is essential to monitor for recurrence and treatment-related late effects.

Common questions about Malignant germ cell tumor of the vagina